MS062202-0083_STARTER

Research code: MS062202-0083_STARTER
Research name: Prospective non-interventional study to evaluate the response to first-line treatment of metastatic colorectal cancer with Cetuximab in combination with FOLFIRI according to tumour location in patients with wild-type RAS/BRAF mutations, with lesions periodically introduced by the Sponsor.
Indication: colorectal cancer
Principal researcher: Ewa Chmielowska, MD, PhD